Chairman and Executive Director Cai Dongchen increases holdings in CSPC PHARMA (01093) by 6.706 million shares at a price of HK$8.85 per share.
On December 23, Chairman and Executive Director Cai Dongchen increased his holdings of Sino Pharmaceutical Group (01093) by 6.706 million shares, with a price of 8.85 Hong Kong dollars per share, for a total amount of approximately 593.481 million Hong Kong dollars.
The latest information from the Hong Kong Stock Exchange shows that on December 23rd, Chairman and Executive Director Cai Dongchen increased his holdings of CSPC PHARMA (01093) by 6.706 million shares, with a price of 8.85 Hong Kong dollars per share, for a total amount of approximately 59.3481 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 2.917 billion shares, with a latest shareholding percentage of 25.31%.
Related Articles

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


